Company: KROS
Filing Date: 2025-04-23
Form Type: DEF 14A
Source: 0001104659-25-037982
Chunk: 84

Company: Keros Therapeutics, Inc.
Filing Date: 2025-04-23
Form: DEF 14A
Chunk 84
---
 of the relationships between information presented in the Pay Versus Performance table above. CAP and Net Loss Because the Company is a pre-commercial stage company, we had no revenue during the periods presented, other than revenue associated with our license agreement with Hansoh (Shanghai) Healthtech Co., Ltd. (“ Hansoh ”), which we entered into in December 2021, a related manufacturing technology transfer agreement we entered into with Hansoh effective June 2023 and a related clinical product supply agreement we entered into with Hansoh effective February 2024. Consequently, we do not use net loss as a performance measure in our executive compensation program. Moreover, as a pre-commercial stage company with only limited, non-recurring revenue associated with our agreements with Hansoh, we do not believe there is any meaningful relationship between our net loss and CAP to our NEOs during the periods presented. The graph below illustrates the relationship between our CAP and the Company’s financial performance over the four-year period shown in the tables above. CAP and Cumulative TSR The graph below shows the relationship between the CAP to our PEO and the average CAP to our non-PEO NEOs, on the one hand, to the Company’s cumulative TSR over the four years presented in the table, on the other. In addition, the graph further illustrates the relationship between our TSR and that of the NASDAQ Biotechnology Index. 58 TABLE OF CONTENTS All information provided above under the “Item 402(v) Pay Versus Performance” heading will not be deemed to be incorporated by reference into any filing of the Company under the Exchange Act, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing, except to the extent the Company specifically incorporates such information by reference. 59

TABLE OF CONTENTS

NON-EMPLOYEE DIRECTOR COMPENSATION The following table sets forth information regarding compensation earned by or paid to our non-employee directors for the fiscal year ended December 31, 2024:

| Name                     | ​ | ​ | Fees Earned orPaid in Cash(1) |   |        |   | ​ | ​ | OptionAwards(2)(3) |   |         |   | ​ | ​ | Total |   |         |   | ​ |
|:-------------------------|:--|:--|:------------------------------|:--|-------:|:--|:--|:--|:-------------------|:--|--------:|:--|:--|:--|: